[{"Assets_0_Q2_USD":40946500000.0,"EarningsPerShareBasic_1_Q2_USD":0.96,"EarningsPerShareBasic_2_Q2_USD":0.85,"EarningsPerShareDiluted_1_Q2_USD":0.95,"EarningsPerShareDiluted_2_Q2_USD":0.85,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1991000000.0,"NetIncomeLoss_1_Q2_USD":1008000000.0,"NetIncomeLoss_2_Q2_USD":897200000.0,"StockholdersEquity_0_Q2_USD":14100800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1057100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1057500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1055000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1055600000.0,"Ticker":"LLY","CIK":"59478","name":"LILLY ELI & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282856619893.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20170728"}]